Reaktionsgleichung
[F:1][C:2]1[CH:3]=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:5]=[C:6]2[C:10]=1[NH:9][CH:8]=[CH:7]2.Br[C:16]1[N:17]=[C:18]([O:21][CH:22]2[CH2:27][CH2:26][N:25]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:24][CH2:23]2)[S:19][CH:20]=1>>[F:1][C:2]1[CH:3]=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:5]=[C:6]2[C:10]=1[N:9]([C:16]1[N:17]=[C:18]([O:21][CH:22]3[CH2:27][CH2:26][N:25]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:24][CH2:23]3)[S:19][CH:20]=1)[CH:8]=[CH:7]2Komponenten
3
Versuchsvorschrift
The title compound was prepared by following the similar procedure as described in Example-1 using 7-Fluoro-5-(methylsulfonyl)-1H-indole (intermediate 22) and tert-butyl 4-((4-bromothiazol-2-yl)oxy)piperidine-1-carboxylate (intermediate 46).
Quellen und Nachweise
- ORD-Eintrag
- ord-ce0634d2162c4b5bb0fd605f63d8d58c
- Quelldatensatz
- uspto-grants-2015_04
- Patentnummer
- US09000175B2
Verknüpfte Notizen
Wird geladen…